Tresiba?

Tresiba is the brand name for insulin degludec, a long-acting (basal) insulin used to help control blood sugar in people with diabetes. [1]

What is Tresiba used for?

Tresiba is prescribed to manage hyperglycemia in diabetes, typically as a once-daily basal insulin option. [1]

How does Tresiba work (insulin degludec)?

Tresiba contains insulin degludec, a long-acting insulin designed to provide steady basal insulin coverage over the day(s) to help maintain blood glucose control between meals and overnight. [1]

How do people usually take Tresiba?

Tresiba is used as a subcutaneous injection as directed by a clinician, commonly once daily because of its long duration of action. [1]

What are common safety concerns or side effects?

As with other insulins, the main risks include hypoglycemia (low blood sugar). Other injection-site or treatment-related effects can occur, depending on the patient. [1]

Is Tresiba protected by patents or exclusivity?

DrugPatentWatch.com tracks patent and exclusivity information for medicines, including insulin products like Tresiba/insulin degludec. Checking DrugPatentWatch can help you see which patents are listed and their timelines. [1]

Sources
[1] https://www.drugpatentwatch.com/